NeoGenomics
NEO
15.97
-0.54
-3.24%
NeoGenomics
US · NEO
#2660 by market cap
Listed 1970
15.97
-0.54
-3.24%
Live - 5344 symbols - heartbeat 193s ago
· 2026-10-08 08:39
Pre-market
15.71
-1.66%
After-hours
15.97
0.00%
Overnight
16.02
+0.31%
- Market cap
- 2.05B
- P/E (TTM)i
- -40.95
- P/Bi
- 2.61
- EPSi
- -0.84
- Div yieldi
- 0.00%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on NEO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.8 percentage points.
Institutional ownership
- Held by institutions
- 113.88% -0.79pp
- Institutions
- 308 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund91.03%
Hedge Fund18.52%
Public Company2.33%
Individual/Insider2.14%
Government Pension Fund1.14%
Private Company0.57%
Insurance Company0.15%
Top holders as of 2026-06-30
BlackRock
16.24% · 20.87M sh
First Light Asset Management, LLC
9.56% · 12.28M sh
First Trust Advisors L.P.
7.87% · 10.11M sh
Greenhouse Funds LLLP
6.67% · 8.57M sh
Vanguard Portfolio Management, LLC
6.27% · 8.06M sh
Vanguard Capital Management, LLC
5.16% · 6.63M sh
State Street Global Advisors
4.17% · 5.36M sh
Macquarie Investment Management Business Trust
3.92% · 5.04M sh
Braidwell LP
3.83% · 4.92M sh
Schroder Investment Management North America Inc.
3.38% · 4.34M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 33 buys · 15 sells
| Name | Role | Stake |
|---|---|---|
| Christopher Smith | Chief Executive Officer | 0.58% |
| Jeffrey Sherman | Chief Financial Officer | 0.17% |
| Melody Harris | President of Enterprise Operations | 0.14% |
| Warren Stone | President of Clinical Division | 0.14% |
| Anthony Zook | Independent Director | 0.12% |
| Alison Hannah | Member of Scientific Advisory Board & Independent Director | 0.10% |
| Lynn Tetrault | Independent Chairperson | 0.07% |
| Alicia Olivo | General Counsel | 0.07% |
| Stephen Kanovsky | Independent Director | 0.06% |
| Michael Kelly | Independent Director | 0.06% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Warren Stone | President of Clinical Division | Derivative Exercise and Sale | -6,911 | -- |
| 2026-09-30 | Warren Stone | President of Clinical Division | Derivative Exercise and Retained | +10,651 | -- |
| 2026-08-31 | Alicia Olivo | General Counsel | Sale to Issuer | -2,692 | -- |
| 2026-08-20 | Warren Stone | President of Clinical Division | Derivative Exercise and Sale | -11,060 | -- |
| 2026-08-20 | Warren Stone | President of Clinical Division | Derivative Exercise and Retained | +17,046 | -- |
| 2026-08-03 | Gregory Aunan | Chief Accounting Officer | Open Market Disposition | -20,000 | $16.07 |
| 2026-07-29 | Jeffrey Sherman | Chief Financial Officer | Intent to Sell (Form 144) | -236,876 | $15.64 |
| 2026-06-14 | Lynn Tetrault | Independent Chairperson | Open Market Disposition | -5,307 | $11.10 |
| 2026-06-08 | Lynn Tetrault | Independent Chairperson | Open Market Disposition | -5,307 | $11.29 |
| 2026-05-31 | Michael Kelly | Independent Director | Other Derivative Acquisition | +11,069 | $10.52 |
| 2026-05-31 | Michael Kelly | Independent Director | Other Derivative Acquisition | +15,970 | -- |
| 2026-05-31 | Michael Kelly | Independent Director | Derivative Exercise and Retained | +23,077 | -- |
| 2026-05-31 | David Perez | Independent Director | Other Derivative Acquisition | +11,069 | $10.52 |
| 2026-05-31 | David Perez | Independent Director | Other Derivative Acquisition | +15,970 | -- |
| 2026-05-31 | David Perez | Independent Director | Derivative Exercise and Retained | +23,077 | -- |
| 2026-05-31 | Lynn Tetrault | Independent Chairperson | Other Derivative Acquisition | +11,069 | $10.52 |
| 2026-05-31 | Lynn Tetrault | Independent Chairperson | Other Derivative Acquisition | +15,970 | -- |
| 2026-05-31 | Lynn Tetrault | Independent Chairperson | Derivative Exercise and Retained | +23,077 | -- |
| 2026-05-31 | Felicia Williams | Independent Director | Other Derivative Acquisition | +11,069 | $10.52 |
| 2026-05-31 | Felicia Williams | Independent Director | Other Derivative Acquisition | +15,970 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:39:56 · For reference only, not investment advice and not tailored to your situation.